Cargando…

Hepatic Clostridium Perfringens Abscess Formation after Radiofrequency Ablation Therapy for Hepatocellular Carcinoma: Report of a Rare Case

Liver abscess formation is one of the major complications following radiofrequency ablation (RFA) in patients with hepatocellular carcinoma (HCC). Clostridium perfringens is a rare but fatal (mortality rate: 70–100%) organism that could lead to severe sepsis. We presented a case where a 63-year-old...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ming-Hung, Kuo, Yuan-Hung, Yen, Yi-Hao, Lu, Sheng-Nan, Wang, Jing-Houng, Chen, Chien-Hung, Hung, Chao-Hung, Kee, Kwong-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261265/
https://www.ncbi.nlm.nih.gov/pubmed/34267637
http://dx.doi.org/10.1159/000517024
_version_ 1783718978643820544
author Wang, Ming-Hung
Kuo, Yuan-Hung
Yen, Yi-Hao
Lu, Sheng-Nan
Wang, Jing-Houng
Chen, Chien-Hung
Hung, Chao-Hung
Kee, Kwong-Ming
author_facet Wang, Ming-Hung
Kuo, Yuan-Hung
Yen, Yi-Hao
Lu, Sheng-Nan
Wang, Jing-Houng
Chen, Chien-Hung
Hung, Chao-Hung
Kee, Kwong-Ming
author_sort Wang, Ming-Hung
collection PubMed
description Liver abscess formation is one of the major complications following radiofrequency ablation (RFA) in patients with hepatocellular carcinoma (HCC). Clostridium perfringens is a rare but fatal (mortality rate: 70–100%) organism that could lead to severe sepsis. We presented a case where a 63-year-old woman with diabetes mellitus, hypertension, chronic hepatitis B-related cirrhosis in Child-Pugh class A and HCC with initial TNM stage II who had undergone 2 sessions of transarterial chemoembolization. RFA was performed for 4 small HCC due to poor effect of previous transarterial chemoembolization. However, all 4 treated tumors developed liver abscesses presenting with septic shock within 1 day. Aspirated abscesses and blood culture both yielded C. perfringens infection. After intensive care, optimal intravenous antibiotic, and abscesses aspiration, the patient recovered successfully. All tumors achieved complete response during the follow-up period without local recurrence. The clinical presentations and risk factors of C. perfringens−related liver abscess after RFA will be discussed in this manuscript.
format Online
Article
Text
id pubmed-8261265
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-82612652021-07-14 Hepatic Clostridium Perfringens Abscess Formation after Radiofrequency Ablation Therapy for Hepatocellular Carcinoma: Report of a Rare Case Wang, Ming-Hung Kuo, Yuan-Hung Yen, Yi-Hao Lu, Sheng-Nan Wang, Jing-Houng Chen, Chien-Hung Hung, Chao-Hung Kee, Kwong-Ming Case Rep Oncol Case Report Liver abscess formation is one of the major complications following radiofrequency ablation (RFA) in patients with hepatocellular carcinoma (HCC). Clostridium perfringens is a rare but fatal (mortality rate: 70–100%) organism that could lead to severe sepsis. We presented a case where a 63-year-old woman with diabetes mellitus, hypertension, chronic hepatitis B-related cirrhosis in Child-Pugh class A and HCC with initial TNM stage II who had undergone 2 sessions of transarterial chemoembolization. RFA was performed for 4 small HCC due to poor effect of previous transarterial chemoembolization. However, all 4 treated tumors developed liver abscesses presenting with septic shock within 1 day. Aspirated abscesses and blood culture both yielded C. perfringens infection. After intensive care, optimal intravenous antibiotic, and abscesses aspiration, the patient recovered successfully. All tumors achieved complete response during the follow-up period without local recurrence. The clinical presentations and risk factors of C. perfringens−related liver abscess after RFA will be discussed in this manuscript. S. Karger AG 2021-06-17 /pmc/articles/PMC8261265/ /pubmed/34267637 http://dx.doi.org/10.1159/000517024 Text en Copyright © 2021 by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Wang, Ming-Hung
Kuo, Yuan-Hung
Yen, Yi-Hao
Lu, Sheng-Nan
Wang, Jing-Houng
Chen, Chien-Hung
Hung, Chao-Hung
Kee, Kwong-Ming
Hepatic Clostridium Perfringens Abscess Formation after Radiofrequency Ablation Therapy for Hepatocellular Carcinoma: Report of a Rare Case
title Hepatic Clostridium Perfringens Abscess Formation after Radiofrequency Ablation Therapy for Hepatocellular Carcinoma: Report of a Rare Case
title_full Hepatic Clostridium Perfringens Abscess Formation after Radiofrequency Ablation Therapy for Hepatocellular Carcinoma: Report of a Rare Case
title_fullStr Hepatic Clostridium Perfringens Abscess Formation after Radiofrequency Ablation Therapy for Hepatocellular Carcinoma: Report of a Rare Case
title_full_unstemmed Hepatic Clostridium Perfringens Abscess Formation after Radiofrequency Ablation Therapy for Hepatocellular Carcinoma: Report of a Rare Case
title_short Hepatic Clostridium Perfringens Abscess Formation after Radiofrequency Ablation Therapy for Hepatocellular Carcinoma: Report of a Rare Case
title_sort hepatic clostridium perfringens abscess formation after radiofrequency ablation therapy for hepatocellular carcinoma: report of a rare case
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261265/
https://www.ncbi.nlm.nih.gov/pubmed/34267637
http://dx.doi.org/10.1159/000517024
work_keys_str_mv AT wangminghung hepaticclostridiumperfringensabscessformationafterradiofrequencyablationtherapyforhepatocellularcarcinomareportofararecase
AT kuoyuanhung hepaticclostridiumperfringensabscessformationafterradiofrequencyablationtherapyforhepatocellularcarcinomareportofararecase
AT yenyihao hepaticclostridiumperfringensabscessformationafterradiofrequencyablationtherapyforhepatocellularcarcinomareportofararecase
AT lushengnan hepaticclostridiumperfringensabscessformationafterradiofrequencyablationtherapyforhepatocellularcarcinomareportofararecase
AT wangjinghoung hepaticclostridiumperfringensabscessformationafterradiofrequencyablationtherapyforhepatocellularcarcinomareportofararecase
AT chenchienhung hepaticclostridiumperfringensabscessformationafterradiofrequencyablationtherapyforhepatocellularcarcinomareportofararecase
AT hungchaohung hepaticclostridiumperfringensabscessformationafterradiofrequencyablationtherapyforhepatocellularcarcinomareportofararecase
AT keekwongming hepaticclostridiumperfringensabscessformationafterradiofrequencyablationtherapyforhepatocellularcarcinomareportofararecase